Macquarie Group LTD Petmed Express Inc Transaction History

Macquarie Group LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$3.95 - $4.84 $4,104 - $5,028	1,039 New	1,039 $4,000
Q3 2022 Nov 14, 2022	SELL	$19.35 - $23.52 $176,259 - $214,243	-9,109 Reduced 96.49%	331 $14,000
Q2 2022 Aug 15, 2022	SELL	$19.9 - $26.13 $110,743 - $145,413	-5,565 Reduced 37.09%	9,440 $187,000
Q1 2022 May 16, 2022	BUY	$23.62 - $29.18 $337,364 - $416,777	14,283 Added 1978.25%	15,005 $388,000
Q1 2021 May 14, 2021	SELL	$29.77 - $51.8 $5,507 - $9,583	-185 Reduced 20.4%	722 $25,000
Q2 2020 Aug 11, 2020	BUY	$27.94 - $40.96 $25,341 - $37,150	907 New	907 $32,000
Q2 2018 Aug 14, 2018	SELL	$33.46 - $46.17 $274,372 - $378,594	-8,200 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$41.2 - $53.24 $20,600 - $26,620	500 Added 6.49%	8,200 $342,000
Q4 2017 Feb 15, 2018	SELL	$34.19 - $48.11 $331,643 - $466,667	-9,700 Reduced 55.75%	7,700 $350,000
Q3 2017 Nov 08, 2017	BUY	$33.15 - $48.95 $576,810 - $851,730	17,400	17,400 $577,000

102

9.52M

39.6K

137K

Ticker PETS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 21,013,800
Market Cap $111M
Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.